DNA Methylation Biomarkers in Asthma and Allergy

Avery DeVries, Donata Vercelli

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

The role of epigenetic processes, primarily DNA methylation, in allergic disease susceptibility and severity is actively explored because of the inability of genetic factors to explain more than a small proportion of the variance in disease phenotype and the functional link among epigenetic mechanisms, environmental exposures, and developmental programs. To date, a number of genome-wide and candidate-gene DNA methylation studies have been performed in populations with asthma, allergic rhinitis, or atopic dermatitis, focusing not only on peripheral blood but also on airway tissue and lesional skin. Differential DNA methylation was detected at biologically plausible loci, but these initial studies should be considered exploratory because of potential issues with population design, size, and phenotypic heterogeneity. Studies leveraging DNA methylation data as clinical biomarkers are also beginning. Future work in longitudinal mother-child birth cohorts will likely highlight the contribution that methylome screens can give to the clinical management of allergic disease and unveil the role played by epigenetic mechanisms in allergic disease pathogenesis.

Original languageEnglish (US)
Title of host publicationEpigenetic Biomarkers and Diagnostics
PublisherElsevier Inc.
Pages331-350
Number of pages20
ISBN (Electronic)9780128019214
ISBN (Print)9780128018996
DOIs
StatePublished - Jan 1 2015

Fingerprint

Allergies
Biomarkers
DNA Methylation
Hypersensitivity
Asthma
Epigenomics
Genes
Genetic Epigenesis
Disease Susceptibility
Environmental Exposure
Atopic Dermatitis
Disease Management
Population Density
Skin
Blood
Mothers
Parturition
Genome
Tissue
Phenotype

Keywords

  • Allergy
  • Asthma
  • DNA methylation
  • Epigenetics

ASJC Scopus subject areas

  • Medicine(all)
  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

DeVries, A., & Vercelli, D. (2015). DNA Methylation Biomarkers in Asthma and Allergy. In Epigenetic Biomarkers and Diagnostics (pp. 331-350). Elsevier Inc.. https://doi.org/10.1016/B978-0-12-801899-6.00017-6

DNA Methylation Biomarkers in Asthma and Allergy. / DeVries, Avery; Vercelli, Donata.

Epigenetic Biomarkers and Diagnostics. Elsevier Inc., 2015. p. 331-350.

Research output: Chapter in Book/Report/Conference proceedingChapter

DeVries, A & Vercelli, D 2015, DNA Methylation Biomarkers in Asthma and Allergy. in Epigenetic Biomarkers and Diagnostics. Elsevier Inc., pp. 331-350. https://doi.org/10.1016/B978-0-12-801899-6.00017-6
DeVries A, Vercelli D. DNA Methylation Biomarkers in Asthma and Allergy. In Epigenetic Biomarkers and Diagnostics. Elsevier Inc. 2015. p. 331-350 https://doi.org/10.1016/B978-0-12-801899-6.00017-6
DeVries, Avery ; Vercelli, Donata. / DNA Methylation Biomarkers in Asthma and Allergy. Epigenetic Biomarkers and Diagnostics. Elsevier Inc., 2015. pp. 331-350
@inbook{92278f5680ea4b10a769235c24600a67,
title = "DNA Methylation Biomarkers in Asthma and Allergy",
abstract = "The role of epigenetic processes, primarily DNA methylation, in allergic disease susceptibility and severity is actively explored because of the inability of genetic factors to explain more than a small proportion of the variance in disease phenotype and the functional link among epigenetic mechanisms, environmental exposures, and developmental programs. To date, a number of genome-wide and candidate-gene DNA methylation studies have been performed in populations with asthma, allergic rhinitis, or atopic dermatitis, focusing not only on peripheral blood but also on airway tissue and lesional skin. Differential DNA methylation was detected at biologically plausible loci, but these initial studies should be considered exploratory because of potential issues with population design, size, and phenotypic heterogeneity. Studies leveraging DNA methylation data as clinical biomarkers are also beginning. Future work in longitudinal mother-child birth cohorts will likely highlight the contribution that methylome screens can give to the clinical management of allergic disease and unveil the role played by epigenetic mechanisms in allergic disease pathogenesis.",
keywords = "Allergy, Asthma, DNA methylation, Epigenetics",
author = "Avery DeVries and Donata Vercelli",
year = "2015",
month = "1",
day = "1",
doi = "10.1016/B978-0-12-801899-6.00017-6",
language = "English (US)",
isbn = "9780128018996",
pages = "331--350",
booktitle = "Epigenetic Biomarkers and Diagnostics",
publisher = "Elsevier Inc.",
address = "United States",

}

TY - CHAP

T1 - DNA Methylation Biomarkers in Asthma and Allergy

AU - DeVries, Avery

AU - Vercelli, Donata

PY - 2015/1/1

Y1 - 2015/1/1

N2 - The role of epigenetic processes, primarily DNA methylation, in allergic disease susceptibility and severity is actively explored because of the inability of genetic factors to explain more than a small proportion of the variance in disease phenotype and the functional link among epigenetic mechanisms, environmental exposures, and developmental programs. To date, a number of genome-wide and candidate-gene DNA methylation studies have been performed in populations with asthma, allergic rhinitis, or atopic dermatitis, focusing not only on peripheral blood but also on airway tissue and lesional skin. Differential DNA methylation was detected at biologically plausible loci, but these initial studies should be considered exploratory because of potential issues with population design, size, and phenotypic heterogeneity. Studies leveraging DNA methylation data as clinical biomarkers are also beginning. Future work in longitudinal mother-child birth cohorts will likely highlight the contribution that methylome screens can give to the clinical management of allergic disease and unveil the role played by epigenetic mechanisms in allergic disease pathogenesis.

AB - The role of epigenetic processes, primarily DNA methylation, in allergic disease susceptibility and severity is actively explored because of the inability of genetic factors to explain more than a small proportion of the variance in disease phenotype and the functional link among epigenetic mechanisms, environmental exposures, and developmental programs. To date, a number of genome-wide and candidate-gene DNA methylation studies have been performed in populations with asthma, allergic rhinitis, or atopic dermatitis, focusing not only on peripheral blood but also on airway tissue and lesional skin. Differential DNA methylation was detected at biologically plausible loci, but these initial studies should be considered exploratory because of potential issues with population design, size, and phenotypic heterogeneity. Studies leveraging DNA methylation data as clinical biomarkers are also beginning. Future work in longitudinal mother-child birth cohorts will likely highlight the contribution that methylome screens can give to the clinical management of allergic disease and unveil the role played by epigenetic mechanisms in allergic disease pathogenesis.

KW - Allergy

KW - Asthma

KW - DNA methylation

KW - Epigenetics

UR - http://www.scopus.com/inward/record.url?scp=85018799193&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85018799193&partnerID=8YFLogxK

U2 - 10.1016/B978-0-12-801899-6.00017-6

DO - 10.1016/B978-0-12-801899-6.00017-6

M3 - Chapter

AN - SCOPUS:85018799193

SN - 9780128018996

SP - 331

EP - 350

BT - Epigenetic Biomarkers and Diagnostics

PB - Elsevier Inc.

ER -